Oral-Turinabol
Stan · Oral turinabol · Oral turinabo · turinabol-oral · Turinabol 25mg · 4-Chlorodianabol · 4-Chlordehydromethyl · turinabol-oral Tbol
Identifikatoren & physikalische Daten
| CAS No. | 2446-23-3 |
|---|---|
| Summenformel | C20H27ClO2 |
| Durchschnittliche Molmasse | 334,9 g/mol |
| Monoisotopische Masse | 334,1699578 g/mol |
| SMILES | C[C@]12C=CC(=O)C(Cl)=C1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O |
| InChIKey | AGUNEISBPXQOPA-XMUHMHRVSA-N |
| PubChem CID | 98521 |
| ChEBI | CHEBI:166768 |
| EC No. | 962-211-2 |
| DTXSID | DTXSID10179216 |
Chemische & physikalische Eigenschaften
| XLogP | 4,4 |
|---|---|
| Polarare Oberfläche (TPSA) | 37,3 |
| H-Brücken-Donoren | 1 |
| H-Brücken-Akzeptoren | 2 |
| Frei drehbare Bindungen | 0 |
| Schwere Atome | 23 |
| Formalladung | 0 |
| Komplexität | 636 |
| Arzneimittel | DEA NFLIS-Drug Category -> SteroidsDEA Schedule III Controlled Substance -> Anabolic steroids |
| Endocrine Disruptors | Potential endocrine disrupting compound |
| Schmelzpunkt | 125 - 127 °C149-151 °C(Solv: acetone (67-64-1)hexane (110-54-3)) |
| Physical Description | Solid |
| Siedepunkt | 464.4±45.0 °C(Predicted) |
| Dichte | 1.20±0.1 g/cm3(Predicted) |
| Löslichkeit | Acetonitrile: 1 mg/mlEthanol: 1 mg/mlMethanol: 1 mg/ml |
| Aggregatzustand | A crystalline solid |
| pKa (Säurekonstante) | 15.05±0.70(Predicted) |
| InChI | InChI=1/C20H27ClO2/c1-18-9-8-16(22)17(21)15(18)5-4-12-13(18)6-10-19(2)14(12)7-11-20(19,3)23/h8-9,12-14,23H,4-7,10-11H2,1-3H3/t12-,13+,14+,18-,19+,20+/s3 |
| InChIKey | AGUNEISBPXQOPA-RFNNMYDSNA-N |
| SMILES | C[C@]12C=CC(=O)C(Cl)=C1CC[C@@]1([H])[C@]3([H])CC[C@@](O)(C)[C@@]3(C)CC[C@]21[H] |&1:1,11,13,17,20,24,r| |
Sicherheit & Vorschriften
| GHS-Einstufung | DangerH350 (50%): May cause cancer [Danger Carcinogenicity]P203, P260, P263, P264, P270, P273, P280, P318, P319, P391, P405, and P501 (click each P-code to see the statement)Aggregated GHS information provided per 2 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies. |
|---|---|
| Regulatorische Informationen | DEA schedule III controlled substance |
| Hazard Classes and Categories | Carc. 1B (50%) |
| DEA Controlled Substances | CSCN: 4000CSA SCH: Schedule IIINARC: No |
Anwendungen & Verwendung
Beschreibung
4-Chlorodehydromethyltestosterone (CDMT; brand name Oral Turinabol), also known as Chlorodehydromethyltestosterone, is an anabolic–androgenic steroid (AAS). It is the 4-chloro-substituted derivative of metandienone (dehydromethyltestosterone). Turinabol is indicated for hormone replacement therapy in men suffering from androgen deficiency or in severe cases of catabolism.
History
4-Chlorodehydromethyltestosterone is an anabolic steroid developed in the 1960s, a highly competitive time for the Olympics and national level sports, the East German experts were looking for effective steroids that would circumvent these sports'drug testing policies. The product was introduced for clinical use in 1965 and remained in use until 1994, when production was discontinued.
Verwenden
4-Chlorodehydromethyltestosterone is a derivative of dehydrochloromethyltestosterone. Metabolite of anabolic steroids. it can produce quality gains in muscle mass as well as strength, even if these gains are not as dramatic or quick as you might get from an aromatizable, or more androgenic oral steroid.